EU COVID-19 Rapid Antigen Tests Common List Inclusion of YHLO GLINE-2019-nCoV Ag
Time Posted ：2024-04-03
After being successfully granted official approval by the German PEI, YHLO’s rapid antigen test product GLINE-2019-nCoV Ag is officially listed on the EU COVID-19 Rapid Antigen Tests Common List on 8th December, 2021.
View Details
YHLO Receives FDA 510(K) Clearance for iFlash 1800 Chemiluminescence Immunoassay Analyzer and iFlash Total βhCG Assay
Time Posted ：2024-04-03
YHLO Biotech announced today that the iFlash 1800 Chemiluminescence Immunoassay Analyzer and iFlash Total βhCG Assay have received a 510(k) clearance from the U.S. Food and Drug Administration through a local partner. A 510(K) is a premarket submission made to FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent as predicate device. Receiving the 510(K) expands YHLO’s reach of iFlash 1800, as it has been installed in nearly 100 counties globally.
View Details
Congrats! YHLO Received CE mark on COVID-19 Ag Self-Test Kit
Time Posted ：2024-04-03
Recently, YHLO proudly announced that the COVID-19 self-test kit, GLINE-2019-nCoV Ag, has received the EC Certificate from the Polish Centre for Testing and Certification (POLSKIE CENTRUM BADAN I CERTYFIKACJI S.A.).
View Details
YHLO COVID-19 Rapid Ag Test Kits(self-test) Approved by BfArM
Time Posted ：2024-04-03
YHLO COVID-19 self-test kit, GLINE-2019-nCoV Ag assay was granted special approval by the German Federal Institute for Drugs and Medical Devices (BfArM) in Germany.
View Details
Rheumatoid Awareness Day: It Is Also An Immune System Disease
Time Posted ：2024-04-03
Rheumatoid Awareness Day, initiated by the Rheumatoid Patient Foundation, is held every year on February 2, to raise awareness for patients with rheumatoid arthritis.
View Details
World Cancer Day: Close the Care Gap
Time Posted ：2024-04-03
February 4 is World Cancer Day. Cancer is a leading cause of death worldwide, and according to data released by the World Health Organization, in 2020, 19.3 million new cases of cancer and nearly 10 million deaths were recorded worldwide. The most common in 2020 (in terms of new cases of cancer) were:
View Details
YHLO produced COVID-19 Rapid Test Authorized by Japanese PMDA
Time Posted ：2024-04-03
On February 10th, 2022, YHLO produced COVID-19 Rapid Antigen Test Kit was authorized by Japanese PMDA (Pharmaceuticals and Medical Devices Agency), which is supplied to YHLO’s Japanese marketing authorization holder, MBL (MEDICAL & BIOLOGICAL LABORATORIES CO., LTD.). With the Japanese PMDA certificate, the product will be available for sale in Japan, which can be used for professional use and self-testing.
View Details
YHLO And C-Mer Donated 300,000 COVID-19 Antigen Tests To Hong Kong
Time Posted ：2024-04-03
On February 16, Shenzhen YHLO and Hong Kong C-Mer (C-Mer Eye Care Holdings Limited) announced that they have donated 300,000 YHLO COVID-19 Rapid Antigen Tests to Hong Kong, joint hands to help Hong Kong citizens to fight against the coronavirus.
View Details
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
